Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Featured trial
ATRA and Carfilzomib in Plasma Cell Myeloma Patients (ATRA)

patients eventually develop disease progression arising from resistance to therapies. As a result, there is an unmet need to overcome resistance and find ways to enhance multiple myeloma sensitivity to

  • 0 views
  • 25 Jun, 2025
Featured trial
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)  

treatment for atopic dermatitis (AD). The trial will enroll adults and adolescents with atopic dermatitis who are culture positive for S. aureus colonization.The primary safety objective of this study

  • 0 views
  • 08 Jul, 2025
  • 7 locations
Featured trial
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Treatment Period 3) Post-treatment Follow-up Period.This study will be conducted in participants with atopic dermatitis (AD) who completed the Treatment Period in a prior APG777 study and who, in the

  • 0 views
  • 15 Jul, 2025
Featured trial
VTP-1000 in Adults with Celiac Disease  

GLU001 is a first-in-human clinical trial to assess the safety and tolerability of VTP-1000 for adults with celiac disease. This trial will assess VTP-1000 at various dose levels compared to

  • 0 views
  • 12 Jun, 2025
Featured trial
Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies (ARCTIC)

This investigation examines the most important cardiovascular risk factors (e.g., metabolic parameters, body composition) and their changes in coeliac disease. The series of studies allow to

  • 0 views
  • 05 Jun, 2025
Featured trial
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

This phase I trial tests the safety of [89Zr]DFO-YS5 positron emission tomography (PET) imaging and how well it works to detect CD46 positive cancer cells in patients with multiple myeloma. [89Zr]DFO-YS5 is an imaging agent called a radiopharmaceutical tracer. A radiopharmaceutical tracer uses a small amount of radioactive material that …

  • 0 views
  • 25 Jun, 2025